Nirvana Health Group’s founder backs health-tech startup HealthSignz

By Keshav Sunkara

  • 31 Jul 2018

Hyderabad-based startup HealthSignz Technologies Pvt. Ltd has raised $5 million (Rs 34.3 crore) in a round led by Kantilal Patel, founder of New Zealand-based Nirvana Health Group, the company said.

The funding round also saw participation from unnamed investors.

The company will use the funds to scale up the technology platform.


The products and services offered by HealthSignz Technologies are powered by its Health Intelligence Engine, which uses artificial intelligence to provide healthcare solutions.

Established in 2014, HealthSignz was founded by Hanumantha Rao, Vinod P Nair, Ram Papa Rao and Surendranath.

HealthSignz offers both business-to-business (B2B) and business-to-consumer (B2C) services.


HealthSignz offers B2C services through its Enliva app. The app helps in booking services such as doctor consultation and wellness services. The other features include generating diet plans and fitness plans. The users can also buy medicines and order lab tests.

The company offers B2B products for healthcare providers including hospitals, pharmacies, wellness centres and diagnostic centres.

Deals in health-tech
A number of startups offering a wide variety of healthcare services have recently caught the attention of investors.
Last week, healthcare investment firm IQGEN Holdings bet on two health-tech ventures: Stelvio Therapeutics, a San Diego-based company that will move its headquarters to India; and Skin Electronics, a Japanese startup. In May, IQGEN put money in RadiomicsAi, a Canada-based AI firm that will transfer its operations to India and other Asian regions.


In June, digital health management platform Navia raised a bridge round of $100,000 (Rs 67 lakh) from existing investor Benori Ventures LLP, which is led by research major Evalueserve’s former chief operating officer Ashish Gupta.

In April, Doxper, an app that helps doctors maintain patients’ medical records, had raised $1.1 million (Rs 7.2 crore) in a pre-Series A round involving existing investors led by Vidal Healthcare.


Share article on